PROLYL HYDROXYLASE INHIBITORS

摘要

Disclosed herein are compositions comprising HIF-1± prolyl hydroxylase inhibitors useful in treating diseases, conditions, and/or syndromes related to the activity of HIF-1±, inter alia, infection, cancer, and wound healing